Clinical Trial Search

Primary: Incidence of Grade 2-4 Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation in Patients Randomized to Photopheresis vs. no Photopheresis — 1; 8…

Primary: Time to Occurrence of Juvenile Rheumatoid Arthritis/Juvenile Idiopathic Arthritis (JRA/JIA) Disease Flare During Double-Blind Phase (Period B) — NA; 6 months — p=0.0002

Primary: Reduction in Pancreatitis Rate — 16.1; 4.9 percentage of participants with PEP

Primary: Mean Percent Excess Weight Loss (%EWL) — 31.5; 9.8 Percent Excess Weight Loss

Primary: QT Interval — 462.8 msec

Primary: Change in Arterial Stiffness Compared to Baseline — -7.2; -7.3 meters / second

Primary: Percentage of Participants Achieving Chemical Castration (Defined as Testosterone Levels ≤ 0.5 ng/mL) at Days 28, 84, and 168. — 98.1 percentage of participants

Primary: Change From Baseline on the Brief Pain Inventory (BPI) 24-Hour Average Pain Score — -2.57; -1.80 units on a scale — p=<.0001

Primary: Number of Participants Rated Very Much Improved on the Global Aesthetic Improvement Scale (GAIS) by Prinicple Investigator — 19 participants

Primary: Time-weighted Average Quantitative Myasthenia Gravis Weakness Score Over 3 Years — 6.15; 8.99 units on a scale

Primary: the Percentage of CD3+/CD4+ Cells Per Cubic Millimeter at the Effector Sites in the Duodenal Tissues Obtained From Volunteers to the Antiretroviral Therapy Regimen Over…

Primary: Composite Functional and Structural Measures - Freedom From Death — 59 Participants

Primary: The Change in Hemoglobin (Hb) From the Day of Surgery — 2.6; 3.2; 2.6; 3.7 g/dl

Primary: Exacerbation Frequency — 0.81; .87 asthma exacerbations per 46 weeks — p=0.67

Primary: Change in Temperature of Pain Threshold — -0.02; -0.61; -0.61; -0.77 Degrees Celsius — p=0.274